Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Pratt

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
The American Journal of Cardiology|April 3, 1998
Impact of managed care on the treatment of atrial fibrillationC M Pratt
Journal of Cardiovascular Electrophysiology|March 25, 1999
Predicting antiarrhythmic performanceC M Pratt
The American Journal of Cardiology|January 16, 1990
The Cardiac Arrhythmia Suppression Trial. Introduction: The aftermath of the CAST--a reconsideration of traditional conceptsC M Pratt
Chest|July 1, 1988
Asymptomatic ventricular arrhythmias in patients with obstructive lung disease. Should they be treated?C M Pratt
The American Journal of Cardiology|February 20, 1990
Proarrhythmic potential of moricizine: strengths and limitations of a data base analysisC M Pratt
The American Journal of Cardiology|July 4, 2001
Analysis of the cilostazol safety databaseC M Pratt
Statistics in Medicine|January 1, 1990
A clinic's perspective on screening, recruitment and data collectionT Eaton, C M Pratt
Chest|January 1, 1988
Application and interpretation of submaximal exercise testing and ambulatory ECG recordings in patients with acute myocardial infarctionC M Pratt, R O'Rourke
The American Journal of Cardiology|January 15, 1989
Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine)J Morganroth, C M Pratt
Journal of Clinical Pharmacology|November 1, 1990
The cardiac arrhythmia suppression trial: implications for antiarrhythmic drug developmentC M Pratt, L Moye
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
The American Journal of Cardiology|April 3, 1998
Impact of managed care on the treatment of atrial fibrillationC M Pratt
Journal of Cardiovascular Electrophysiology|March 25, 1999
Predicting antiarrhythmic performanceC M Pratt
The American Journal of Cardiology|January 16, 1990
The Cardiac Arrhythmia Suppression Trial. Introduction: The aftermath of the CAST--a reconsideration of traditional conceptsC M Pratt
Chest|July 1, 1988
Asymptomatic ventricular arrhythmias in patients with obstructive lung disease. Should they be treated?C M Pratt
The American Journal of Cardiology|February 20, 1990
Proarrhythmic potential of moricizine: strengths and limitations of a data base analysisC M Pratt
The American Journal of Cardiology|July 4, 2001
Analysis of the cilostazol safety databaseC M Pratt
Statistics in Medicine|January 1, 1990
A clinic's perspective on screening, recruitment and data collectionT Eaton, C M Pratt
Chest|January 1, 1988
Application and interpretation of submaximal exercise testing and ambulatory ECG recordings in patients with acute myocardial infarctionC M Pratt, R O'Rourke
The American Journal of Cardiology|January 15, 1989
Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine)J Morganroth, C M Pratt
Journal of Clinical Pharmacology|November 1, 1990
The cardiac arrhythmia suppression trial: implications for antiarrhythmic drug developmentC M Pratt, L Moye
Pageof 13